AgingResearch.News
Animals

Synthetic gene circuit clears protein aggregates and extends lifespan in Huntington disease mice

The sensor-driven system selectively triggers autophagy regulator TFEB upon detecting toxic huntingtin conformers, lowering brain inflammation and rescuing synaptic deficits.

Advanced Science

In R6/2 Huntington's disease mice, an engineered aggregate-responsive gene circuit reduced mutant huntingtin protein burden and prolonged survival. Researchers developed the synthetic ARAA circuit by repurposing a bacterial NarX-NarL system fused with a conformation-sensitive intrabody. This construct detects pathological polyQ aggregates and selectively activates transcription of the master autophagy regulator TFEB. To enable systemic delivery across the blood-brain barrier, the team encapsulated the circuit in CD98-targeted immunoliposomes that cross into the brain via receptor-mediated transcytosis. In treated mice, the circuit lowered neuroinflammation, restored synaptic function, and enhanced motor performance while significantly extending overall lifespan.

Why it matters

The progressive loss of proteostasis and accumulation of misfolded proteins are major drivers of neurodegenerative disease. Directly coupling autophagy activation to the presence of toxic protein conformers demonstrates a targeted strategy to maintain cellular clearance without non-specific induction.

Caveats

This work serves as a proof of concept conducted exclusively in R6/2 mice, an exon 1-based model of Huntington's disease. Whether this synthetic circuit functions safely and effectively in other models or species remains to be determined.

The paper

Huntingtin Aggregate-Responsive Autophagy Gene Circuit Mitigates Disease Pathology in R6/2 Mice

Zhu J, Xie XX, Li L et al.

Advanced Science · 27 Sep 2026